Skip to main content
SpringerLink
Log in

Management of Chronic HBV Infection in Children

  • Chapter
  • First Online:
Viral Hepatitis: Chronic Hepatitis B

  • 658 Accesses

Abstract

Hepatitis B virus (HBV) infection is prevalent worldwide. About ten million people are chronically infected with HBV in Bangladesh, and it is possible that most infections occur during childhood. Overall prevalence is about 3% in Bangladesh. Chronic hepatitis B infection evolves through five phases. Most of the children belong to the immune-tolerant phase. Treatment of chronic hepatitis B is difficult. The goals of therapy are to reduce viral replication, to minimize liver injury, to reduce consequence of liver injury like cirrhosis and hepatocellular carcinoma, and to reduce infectivity of HBV. Treatment should be considered in chronic hepatitis B if patients have persistently elevated ALT of more than twice the normal range and evidence of viral replication. Seroconversion occurs in about 17–32% of cases if treated with oral nucleot(s)ide analogue and in about 58% of cases if treated with interferon. Risk factor identification and prevention of HBV infection is the logical and rational approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. Hepatitis B. 2002. pp. 6–75. Retrieved January 2, 2008, from http://www.who.int/emc.

  2. Ahmad N, Alam S, Mustafa G, Adnan ABM, Baig RH, Khan M. Hepatitis e antigen negative chronic hepatitis B in Bangladesh. HBPD Int. 2008;7:379–82.

    PubMed  CAS  Google Scholar 

  3. Zaki MH, Darmstadt GL, Baten A, Ahsan CR, Saha SK. Seroepidemiology of hepatitis B and Delta virus infection in Bangladesh. J Trop Paediatr. 2003;49:371–4.

    Article  Google Scholar 

  4. Laskar MS, Harada N, Khan F. Prevalence of hepatitis B surface antigen in Viqarunnessa noon Girls’school children in Dhaka, Bangladesh. Centr Eur J Public Health. 1997;5:202–4.

    CAS  Google Scholar 

  5. Jamal CY, Rahman SA, Kawser CA. Prevalence of HBV markers in multi-transfused thalassaemic patients. Bangladesh J Child Health. 1997;21:38–42.

    Google Scholar 

  6. Akhter S, Talukder MQK, Bhuiyan N, Chowdhury TA, Islam MN, Begum S. Hepatitis B virus infection in pregnant mothers and its transmission to infants. Indian J Pediatr. 1992;59:411–5.

    Article  CAS  PubMed  Google Scholar 

  7. Hochman JA, Balistreri WF. Acute and chronic viral hepatitis. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. New York: Cambridge University Press; 2007. p. 382–406.

    Google Scholar 

  8. Rukunuzzaman M, Afroza A. Study of risk factors of hepatitis B virus infection in children. Mymensingh Med J. 2011;20:700–8.

    PubMed  CAS  Google Scholar 

  9. Mahtab MA, Rahman S, Karim MF, Khan M, Foster G, Solaiman S, et al. Epidemiology of hepatitis B virus in Bangladeshi general population. HBPD Int. 2008;7:595–600.

    PubMed  Google Scholar 

  10. Sali S, Bashter R, Alavian SM. Risk factors in chronic hepatitis B infection: a case control study. Hepat Mon. 2005;5:109–15.

    Google Scholar 

  11. Alam MS, Khatoon S, Rima R, Afrin S. The seroprevalence of HBV among children attending urban & rural hospitals. Bangladesh J Child Health. 2006;30:17–21.

    Google Scholar 

  12. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.

    Article  CAS  PubMed  Google Scholar 

  13. Chakravarti A, Rawat D, Jain M. A study on perinatal transmission of the hepatitis B virus. IJMM. 2005;23:128–30.

    PubMed  CAS  Google Scholar 

  14. Batayneh N, Bdour S. Risk of perinatal transmission of the hepatitis B virus in Jordan. Infect Dis Obstet Gynecol. 2002;10:127–32.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Shi Z, Yang Y, Wang H, Ma L, Schreiber A, Li X, et al. Breastfeeding ofnewborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med. 2011;165:837–46.

    Article  PubMed  Google Scholar 

  16. World Health Organization. Hepatitis B and breastfeeding. World Health Organization. JIAPAC. 1998;4:20–1.

    Google Scholar 

  17. Kerkar N. Hepatitis B in children: complexities in management. Paediatr Transplant. 2005;9:685–91.

    Article  Google Scholar 

  18. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–85.

    Article  Google Scholar 

  19. Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and nutrition. J Hepatology. 2013;59:814–29.

    Article  Google Scholar 

  20. Giacchino R, Cappelli B. Treatment of viral hepatitis B in children. Expert Opin Pharmacother. 2010;11:889–903.

    Article  CAS  PubMed  Google Scholar 

  21. Satapathy SK, Garg S, Chauhan R, Malhotra V, Sakhuja P, Sharma BC, et al. Profile of chronic hepatitis B virus in children in India: experience with 116 children. J Gastroenterol Hepatol. 2006;21:1170–6.

    Article  CAS  PubMed  Google Scholar 

  22. Rapti IN, Hadziyannis SJ. Treatment of special populations with chronic hepatitis B infection. Expert Rev Gastroenterol Hepatol. 2011;5:323–39.

    Article  PubMed  Google Scholar 

  23. Schwarz KB, Mohan P, Narkewicz MR, Molleston JP, Nash SR, Hu S, et al. Safety, efficacy and pharmacokinetics of Peginterferon alpha 2a in children in chronic hepatitis C. J Pediatr Gastroenterol Nutr. 2006;43:499–505.

    Article  CAS  PubMed  Google Scholar 

  24. Yuen MF, Lai CL. Treatment of chronic hepatitis B: evolution over two decades. J Gastroenterol Hepatol. 2011;26:138–43.

    Article  PubMed  Google Scholar 

  25. Paganelli M, Stephenne X, Sokal EM. Chronic hepatitis B in children and adolescents. J Hepatol. 2012;57:885–96.

    Article  PubMed  Google Scholar 

  26. Rukunuzzaman M, Afroza A. Clinical, biochemical and Virological profile of chronic hepatitis B virus infection in children. Mymensingh Med J. 2012;21:120–3.

    PubMed  CAS  Google Scholar 

  27. Chang TT, Gish RG, de Man R. A comparison of entecavir and lamivudine for HBeAg positive chronic hepatitis B. N Engl J Med. 2006;354:1001–10.

    Article  CAS  PubMed  Google Scholar 

  28. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ. Long term therapy with adefovir dipivoxil for HBe Ag negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006;131:1743–51.

    Article  CAS  PubMed  Google Scholar 

  29. Seto WK, Lai CL, Fung J, Yuen J, Wong DKH, Yuen MF. A three year study on viral suppression and resistance profile for treatment naive CHB patients receiving continuous entecavir treatment. Hepatol Int. 2010;4:58.

    Google Scholar 

  30. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovirdisoproxilfumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468–75.

    Article  CAS  PubMed  Google Scholar 

  31. WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. March, 2015.

    Google Scholar 

  32. CDC. A compulsive immunization strategy to eliminate transmission of HBV infection in the United States. MMWR. 2005;54:1–23.

    Google Scholar 

  33. Bzowej NH, Hepatitis B. Therapy in pregnancy. Curr Hepat Rep. 2010;9:197–204.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Terrault NA, Jacobson IM. Treating chronic hepatitis B infection in patients, who are pregnant or are undergoing immunosuppressive chemotherapy. Semin Liver Dis. 2007;27(Suppl1):18–24.

    Article  CAS  PubMed  Google Scholar 

  35. Poddar U, Yachha SK, Agarwal J, Krishnani N. Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon? J Viral Hepat. 2013;20:311–6.

    Article  CAS  PubMed  Google Scholar 

  36. D’Antiga L, Aw M, Atkins M, Moorat A, Vergani D, Mieli-Vergani G. Combined lamivudine/interferon-alpha treatment in “immunotolerant” children perinatally infected with hepatitis B: a pilot study. J Pediatr. 2006;148:228–33.

    Article  CAS  PubMed  Google Scholar 

  37. Abaalkhail F, Elsiesy H, Al Omair A, Alghamdi MY, Alalwan A, Al Masri N, et al. SASLT practice guidelines for the Management of Hepatitis B Virus. Saudi J Gastroenterol. 2014;20:5–25.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Gastroenterology and Nutrition, BSMMU, Dhaka, Bangladesh

    Md Rukunuzzaman & Md Benzamin

  2. Dhaka Medical College Hospital, Dhaka, Bangladesh

    Kaniz Sultana

Authors
  1. Md Rukunuzzaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Md Benzamin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kaniz Sultana
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cerrahasa Medical School, Istanbul University, Istanbul, Turkey

    Resat Ozaras

  2. University of Missouri, Columbia, Missouri, USA

    Veysel Tahan

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rukunuzzaman, M., Benzamin, M., Sultana, K. (2018). Management of Chronic HBV Infection in Children. In: Ozaras, R., Tahan, V. (eds) Viral Hepatitis: Chronic Hepatitis B. Springer, Cham. https://doi.org/10.1007/978-3-319-93449-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93449-5_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93448-8

  • Online ISBN: 978-3-319-93449-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation